A bioactive suspension derived from freshly disaggregated tissue is provided, as well as related methods of formulation and use. The bioactive suspension may comprise a cell-free supernate derived from epidermal and dermal tissue that has been enzymatically and mechanically disaggregated, then separated, and which may contain tissue regeneration factors known to speed healing. The bioactive suspension may further comprise genetically-modified treatment cells, wild type cells, or both, and may be combined with one or more scaffolding elements to form a bioactive suspension combination product suitable for treatment of a cutaneous defect. Synthetic bioactive suspensions and bioactive suspension combination products are also provided.

Topical pharmaceutical composition as a dispersed phase based on a short diol in a continuous fatty phase and including an anti-inflammatory substance, the composition including: a gelled phase including an anti-inflammatory substance and a diol including 3-8 carbon atoms and represented either by formula (I.sub.a): R.sup.a.sub.1—(R.sup.b.sub.1)(OH)—(OH)(R.sup.c.sub.1)(R.sup.d.sub.1) (I.sub.a), in which each of the radicals R.sup.a.sub.1, R.sup.b.sub.1, R.sup.c.sub.1 and R.sup.d.sub.1 represents, independently of each other, a hydrogen atom or a saturated aliphatic radical including 1-5 carbon atoms, or by formula (I.sub.b): R.sup.a.sub.1—C(R.sup.b.sub.1)(OH)—[C(R.sup.e.sub.1)(Rf.sub.1)].sub.t—C(OH)(R.sup.c.sub.1)(R.sup.d.sub.1) (I.sub.b), t=1, 2 or 3, each of the radicals R.sup.a.sub.1, R.sup.b.sub.1, R.sup.c.sub.1 R.sup.d.sub.1, R.sup.e.sub.1 and R.sup.f.sub.1 represents, independently of each other, a hydrogen atom or a saturated aliphatic radical including 1-5 carbon atoms. The radicals R.sup.a.sub.1or R.sup.b.sub.1 and/or the radicals R.sup.c.sub.1or R.sup.d.sub.1does not represent a hydrogen atom, a fatty phase including an oil and an emulsifying system including a combination of emulsifying surfactants.

A cancer cell proliferation suppression agent containing, as an active ingredient, an inositol derivative in which a sugar is bound to inositol is provided. Furthermore, a composition for suppressing proliferation of cancer cells containing the above-mentioned cancer cell proliferation suppression agent and a pharmaceutically acceptable carrier is provided.

The inventive subject matter provides kits, compositions and methods for treating or covering skin using a polymerizable formulation. The polymerizable formulation can include a first component including a siloxane polymer and a catalyst, and a second component including a siloxane polymer and a cross-linker. The first and second components, when combined, can form a film or seal having an elasticity that at least one of decreases the formation of fibroblasts, presses down blisters, decreases a biochemical cascade that promotes scar formation, compresses skin, and holds skin in a desired configuration.

Film-forming gel compositions, useful in creating conformable and flexible gel bandages, can be formulate from a film-forming polymer, an amine-rich adhesion promoter, and a volatile solvent. The gel compositions form relatively thick films when dried on tissue, and can exhibit enhanced breathability to promote wound healing. In some cases, the film-forming gel composition can include lidocaine.

The present invention provides a pharmaceutical composition for use in increasing hair, modifying scalp or skin, healing a wound, promoting osteogenesis or modifying hair, the pharmaceutical composition comprising a therapeutically effective amount of a saturated fatty acid or a pharmaceutically acceptable salt thereof as an active ingredient.

An agent for protection against atmospheric pollutants containing a tocopherol phosphate ester or a salt thereof as an active ingredient is provided. A composition for protection against atmospheric pollutants containing the above-mentioned agent for protection against atmospheric pollutants and a pharmaceutically acceptable carrier is further provided.

A pain relieving aerosol spray (pain relieving and pain preventing aerosol spray) comprising a pain relieving composition and at least one refrigerant, wherein the pain relieving aerosol spray is capable of providing rapid onset local anaesthesia of intact skin and/or a wound of a subject to which it is applied and further pain relief due to the pain relieving composition remaining on the wound of the subject. The pain relieving composition comprises a liquid gel matrix that contains at least one anaesthetic agent, a vasoconstrictor, and an antiseptic agent. The spray can be used for a surgical procedure or animal husbandry procedure, such as castration or branding, or treating a burn or wound.

The present invention relates to methods of treating female reproductive tract irritation (such as pain and pruritus) or/and inflammation.

A liquid invisible mask, and a preparation method and a using method thereof are provided by the present disclosure, and the present disclosure relates to the technical field of isolated bacteriostatic protective materials. The liquid invisible mask which is a film covering a surface of a nasal cavity, an oral cavity or a throat mucosa, wherein: the film comprises a garlic extract with garlicin content more than 45%, sesame essential oil and cream; and a mass ratio of the garlic extract, the sesame essential oil and the cream is (70-85): (10-20): (5-10). The present disclosure takes the garlic extract with high content of garlicin as the active component, ensures the basic efficacy of sterilization and toxicity elimination, and is supplemented with sesame essential oil as the film-forming carrier material and cream as the skeleton material.